טוען...
Glibenclamide-induced profound hypoglycaemic crisis: a case report
The value of sulphonylureas in the long-term treatment of type II diabetes has been questioned. The potential benefits of an antidiabetic drug must be carefully weighed against the risk of developing hazardous adverse effects like hypoglycaemia. We present drug-induced hypoglycaemia in a 77-year-old...
שמור ב:
| הוצא לאור ב: | Ther Adv Endocrinol Metab |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4821000/ https://ncbi.nlm.nih.gov/pubmed/27092233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042018816632440 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|